From GlobeNewswire: 2025-05-28 09:35:00

The Global Microcarriers Market size was valued at USD 1.8 billion in 2023 and is projected to reach USD 4.5 billion by 2032, with an annual growth rate of 10.6%. The U.S. market is witnessing robust growth driven by demand for cell-based vaccines and regenerative medicine.

The market is expanding due to increased demand for cell-based vaccines and treatments, as well as advancements in cell culture technologies. Collaborations like Sartorius and Sanofi’s partnership in 2024 show the industry’s commitment to improving bioprocessing technologies.

The microcarriers market is poised for substantial growth due to technological innovations and increasing demand for biopharmaceuticals. The industry is seeing a surge in demand for cell-based therapies, highlighting the urgent need for scalable vaccine production methods.

In 2023, North America dominated the global microcarriers market, accounting for around 45% of revenue share. The U.S. market has seen rapid growth due to increased utilization of microcarriers for cell-based vaccine manufacturing and advancements in cell production technologies.

The Asia Pacific region is expected to see significant growth in the microcarriers market over the forecast period of 2024-2032. Increased investments in healthcare infrastructure and R&D are creating lucrative opportunities for market players in the region. Countries like China, India, and Japan are seeing growth in the biopharmaceutical sector with increased investments and government support. China’s 14th Five-Year Plan focuses on biotechnological advancements, while India’s Biopharma Mission aims to become a global hub for biopharmaceutical innovation.

In August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. partnered to advance cancer cell therapy, reflecting the rising demand for microcarriers in the U.S. due to the increase in chronic disease cases. Lonza Group also collaborated with Moderna in 2023 to scale up mRNA vaccine production using advanced microcarrier-based systems.

The market dynamics impact analysis includes statistics on incidence and prevalence in 2023, prescription trends by region, production and usage volumes of pharmaceuticals, and healthcare spending data. The microcarriers market is segmented by product, cell type, application, and end-use, with a focus on regional analysis and company profiles.

Single-use Bioprocessing Market is projected to reach USD 100.9 billion by 2032 with a 15.9% CAGR growth, driven by increasing demand. The Tissue Engineering Market is set to hit USD 56.2 billion by 2032 with a 14.3% CAGR, while the 3D Cell Culture Market is forecasted to reach USD 4.0 billion by 2032, growing at a 12.4% CAGR.

SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data, consumer insights, and opinions to make informed decisions. Their research techniques include surveys, video talks, and focus groups globally, ensuring clients have the knowledge they need to navigate changing market conditions confidently.



Read more at GlobeNewswire: Microcarriers Market Size to Reach USD 4.5 Billion by 2032,